Cover Image
市場調查報告書

生物MEMS、微流體的全球市場 (2017-2027年):植入式 (生物感應器、支架、藥物輸送、生物晶片、加速計)、注射用 (微針頭、微型組件)、其他

World Bio-MEMS & Microfluidics Market Forecasts 2017-2027: Implantable, Biosensors, Stents, Drug Delivery, Biochips, Accelerometers, Injectable, Microneedles, Micromodules, Inhalers, Catheters, Micro Motors

出版商 Visiongain Ltd 商品編碼 556461
出版日期 內容資訊 英文 206 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生物MEMS、微流體的全球市場 (2017-2027年):植入式 (生物感應器、支架、藥物輸送、生物晶片、加速計)、注射用 (微針頭、微型組件)、其他 World Bio-MEMS & Microfluidics Market Forecasts 2017-2027: Implantable, Biosensors, Stents, Drug Delivery, Biochips, Accelerometers, Injectable, Microneedles, Micromodules, Inhalers, Catheters, Micro Motors
出版日期: 2017年07月25日 內容資訊: 英文 206 Pages
簡介

本報告提供全球生物MEMS及微流體的市場調查,市場定義和概要,市場成長的各種影響因素及市場機會分析,各類型、用途、終端用戶、地區、主要國家趨勢與市場規模的變化與預測,以及主要企業的簡介等彙整。

第1章 報告概要

第2章 簡介

第3章 全球市場的預測

第4章 市場預測:各類型

  • 概要
  • 植入式生物MEMS、微流體
    • 生物感應器
    • 陀螺儀
    • 支架
    • 藥物輸送設備
    • 生物晶片
    • 加速計
  • 注射用生物MEMS、微流體
    • 微針頭
    • 微型組件
  • 其他
    • 吸入器
    • 導管
    • 微電機

第5章 市場預測:各用途

  • 概要
  • 診斷
  • 治療
  • 組織工程
  • 其他

第6章 市場預測:各終端用戶

  • 概要
  • 醫藥品產業
  • 醫院
  • 研究中心
  • 其他

第7章 市場預測:各地區

  • 地區市場預測
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 南美
    • 巴西
    • 阿根廷
    • 巴拉圭
    • 玻利維亞
    • 其他
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 泰國
    • 其他
  • 其他地區
    • 中東
    • 非洲
    • 其他

第8章 定性分析、預測

  • 波特的五力分析
  • 成長推動因素、阻礙要素

第9章 主要企業

  • Abbott Diagnostics
  • Nova Biomedical
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • Fraunhofer-IMS
  • Medtronic PLC
  • Boston Scientific Corporation
  • F. HOFFMANN-LA ROCHE AG
  • Johnson & Johnson
  • Becton, Dickinson and Company

第10章 總論

目錄
Product Code: PHA0216

Title:
World Bio-MEMS & Microfluidics Market Forecasts 2017-2027
Revenue Prospects by Type (Implantable, Biosensors, Stents, Drug Delivery, Biochips, Accelerometers, Injectable, Microneedles, Micromodules, Inhalers, Catheters, Micro Motors), Application (Diagnostic, Therapeutic, Tissue Engineering), End-User (Pharmaceutical Industry, Hospitals, Research Centres) and Geography.

Bio-MEMS and Microfluidics - our new study reveals trends, R&D progress, and predicted revenues

Where is the Bio-MEMS and Microfluidics market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 206-page report provides 204 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 13 Product Types, 3 Applications and 3 End Users.

Global Bio-MEMS & Microfluidics Market segments, by Type

  • Implantable Bio-MEMS
    • Biosensors:
      • Gyroscopes
      • Stents
      • Drug Delivery Devices
      • Biochips
      • Accelerometers
    • Injectable Bio-MEMS:
      • Microneedles
      • Micromodules
    • Other Devices:
      • Inhalers
      • Catheters
      • Micro motors

Global Bio-MEMS & Microfluidics Market segments, by Application

  • Diagnostics
  • Therapeutics
  • Tissue Engineering
  • Others

Global Bio-MEMS & Microfluidics Market segments, by End-User

  • Pharmaceutical Industry
  • Hospitals
  • Research Centres
  • Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 Regional & 17 leading national markets:

  • North America:
    • The US
    • Mexico
    • Canada
  • South America:
    • Brazil
    • Argentina
    • Paraguay
    • Bolivia
    • Rest of South America
  • Europe:
    • Germany
    • France
    • The UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific:
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • Rest of Asia-Pacific
  • Rest of the World:
    • Middle East
    • Africa
    • Other Countries

The report also includes profiles and forecasts for some of the leading companies in the Bio-MEMS and Microfluidics market, with a focus on these segments of the companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth

Overall world revenue for Bio-MEMS and Microfluidics will surpass $2.8bn in 2017, our work calculates. We predict strong revenue growth through to 2027. The increasing prevalence of neurological conditions, increase in diagnostic procedures in emerging economies and increasing ageing population will increase sales to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Bio-MEMS and Microfluidics Market report helps you

In summary, our 206-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the world Bio-MEMS and Microfluidics market and 2 different segmentations, with 13 product categories, 3 applications and 3 end users - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 17 of the leading national markets - US, Mexico, Canada, Brazil, Argentina, Paraguay, Bolivia, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Thailand
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Bio-MEMS and Microfluidics market and leading companies. You find data, trends and predictions.

Get our report today World Bio-MEMS & Microfluidics Market Forecasts 2017-2027 Revenue Prospects by Type (Implantable, Biosensors, Stents, Drug Delivery, Biochips, Accelerometers, Injectable, Microneedles, Micromodules, Inhalers, Catheters, Micro Motors), Application (Diagnostic, Therapeutic, Tissue Engineering), End-User (Pharmaceutical Industry, Hospitals, Research Centres) and Geography. Avoid missing out - get our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Bio-MEMS & Microfluidics Overview
  • 1.2. Research Methodology
    • 1.2.1. Primary Research
    • 1.2.2. Secondary Research
  • 1.3. Market Evaluation & Forecasting Methodology
  • 1.4. Global Bio-MEMS & Microfluidics Market Segmentation
  • 1.5. Overview of Findings
  • 1.6. Why You Should Read This Report
  • 1.7. How this report delivers?
  • 1.8. Key Questions Answered by This Analytical Report
  • 1.9. Frequently Asked Questions (FAQ)
  • 1.10. Who is This Report For?
  • 1.11. Associated Visiongain Reports
  • 1.12. About Visiongain

2. Introduction to Bio-MEMS & Microfluidics

  • 2.1. Applications of Bio-MEMS & Microfluidics
    • 2.1.1. Therapeutics
    • 2.1.2. Diagnostics
    • 2.1.3. Tissue Engineering

3. Global Bio-MEMS & Microfluidics Market Forecast to 2027

4. Global Bio-MEMS & Microfluidics Market by Type: Market Forecast to 2027

  • 4.1. Overview
  • 4.2. Implantable Bio-MEMS & Microfluidics
    • 4.2.1. Biosensors
    • 4.2.2. Gyroscopes
    • 4.2.3. Stents
    • 4.2.4. Drug Delivery Devices
    • 4.2.5. Biochips
    • 4.2.6. Accelerometers
  • 4.3. Injectable Bio-MEMS & Microfluidics
    • 4.3.1. Microneedles
    • 4.3.2. Micromodules
  • 4.4. Others Devices Bio-MEMS & Microfluidics
    • 4.4.1. Inhalers
    • 4.4.2. Catheters
    • 4.4.3. Micro motors

5. Global Bio-MEMS & Microfluidics Market by Application: Market Forecast to 2027

  • 5.1. Overview
  • 5.2. Diagnostic
  • 5.3. Therapeutics
  • 5.4. Tissue Engineering
  • 5.5. Others

6. Global Bio-MEMS & Microfluidics Market by End-User: Market Forecast to 2027

  • 6.1. Overview
  • 6.2. Pharmaceutical Industry
  • 6.3. Hospitals
  • 6.4. Research Centres
  • 6.5. Other Applications

7. Regional Bio-MEMS & Microfluidics Market Forecasts to 2027

  • 7.1. Regional Bio-MEMS & Microfluidics Market Forecast 2017-2027
  • 7.2. North American Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.2.1. USA Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.2.2. Canada Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.2.3. Mexico Bio-MEMS & Microfluidics Market Forecast 2017-2027
  • 7.3. South American Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.3.1. Brazil Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.3.2. Argentina Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.3.3. Paraguay Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.3.4. Bolivia Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.3.5. Rest of South America Bio-MEMS & Microfluidics Market Forecast 2016-2027
  • 7.4. European Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.4.1. France Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.4.2. Germany Bio-MEMS & Microfluidics Market Forecast 2016-2027
    • 7.4.3. UK Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.4.4. Spain Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.4.5. Italy Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.4.6. Rest of Europe Bio-MEMS & Microfluidics Market Forecast 2017-2027
  • 7.5. Asia-Pacific Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.5.1. China Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.5.2. Japan Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.5.3. India Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.5.4. Australia Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.5.5. Thailand Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.5.6. Rest of Asia-Pacific Bio-MEMS & Microfluidics Market Forecast 2017-2027
  • 7.6. Rest of World Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.6.1. Middle East Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.6.2. Africa Bio-MEMS & Microfluidics Market Forecast 2017-2027
    • 7.6.3. Other Countries Bio-MEMS & Microfluidics Market Forecast 2017-2027

8. Bio-MEMS & Microfluidics Market, Qualitative Analysis, 2017-2027

  • 8.1. Porter's Five Forces Analysis
    • 8.1.1. Bargaining Power of Buyers (High)
    • 8.1.2. Bargaining Power of Suppliers (Medium)
    • 8.1.3. Threat of New Entrants (Medium)
    • 8.1.4. Threat of Substitute Products (High)
    • 8.1.5. Intensity of Competitive Rivalry (High)
  • 8.2. Drivers & Restrains
    • 8.2.1. Application of Bio-MEMS in drug delivery
    • 8.2.2. Increase in geriatric population and surge in incidence and prevalence of chronic diseases
    • 8.2.3. Increase in government expenditure in the healthcare sector
    • 8.2.4. Complex regulatory framework
    • 8.2.5. Lucrative opportunities from emerging economies

9. Leading Companies in Bio-MEMS & Microfluidics Market

  • 9.1. Abbott Diagnostics (A Business Division Abbott Laboratories Inc.)
    • 9.1.1. Abbott Diagnostics: Company Overview
    • 9.1.2. Abbott Diagnostics: Product Portfolio
    • 9.1.3. Abbott Diagnostics: Recent Developments
  • 9.2. Nova Biomedical
    • 9.2.1. Nova Biomedical: Company Overview
    • 9.2.2. Nova Biomedical: Product Portfolio
    • 9.2.3. Nova Biomedical: Recent Developments
  • 9.3. Danaher Corporation (Pall ForteBio)
    • 9.3.1. Danaher Corporation: Company Overview
    • 9.3.2. Danaher Corporation: Product Portfolio
    • 9.3.3. Danaher Corporation: Recent Developments
  • 9.4. Thermo Fisher Scientific Inc. (Affymetrix)
    • 9.4.1. Thermo Fisher Scientific Inc.: Company Overview
    • 9.4.2. Thermo Fisher Scientific Inc.: Product Portfolio
    • 9.4.3. Thermo Fisher Scientific Inc.: Recent Developments
  • 9.5. Fraunhofer-IMS
    • 9.5.1. Fraunhofer-IMS: Company Overview
    • 9.5.2. Fraunhofer-IMS: Product Portfolio
  • 9.6. Medtronic PLC
    • 9.6.1. Medtronic PLC: Company Overview
    • 9.6.2. Medtronic PLC: Product Portfolio
    • 9.6.3. Medtronic PLC: Recent Developments
  • 9.7. Boston Scientific Corporation
    • 9.7.1. Boston Scientific Corporation: Company Overview
    • 9.7.2. Boston Scientific Corporation: Product Portfolio
    • 9.7.3. Boston Scientific Corporation: Recent Developments
  • 9.8. F. HOFFMANN-LA ROCHE AG
    • 9.8.1. F. Hoffmann-La Roche: Company Overview
    • 9.8.2. F. Hoffmann-La Roche: Product Portfolio
    • 9.8.3. F. Hoffmann-La Roche: Recent Developments
  • 9.9. Johnson & Johnson
    • 9.9.1. Johnson & Johnson: Company Overview
    • 9.9.2. Johnson & Johnson: Product Portfolio
    • 9.9.3. Johnson & Johnson: Recent Developments
  • 9.10. Becton, Dickinson and Company
    • 9.10.1. Becton, Dickinson and Company: Company Overview
    • 9.10.2. Becton, Dickinson and Company: Product Portfolio
    • 9.10.3. Becton, Dickinson and Company: Recent Developments

10. Conclusions

  • 10.1. Current Leading Segments
  • 10.2. Leading Regional Markets
  • 10.3. Emerging Markets
  • 10.4. The Future of the Market?
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 3.1. Global Bio-MEMS & Microfluidics Market, by Type, ($bn), 2017-2027
  • Figure 3.2. Global Bio-MEMS & Microfluidics Market, by Application, ($bn), 2017-2027
  • Figure 3.3. Global Bio-MEMS & Microfluidics Market, by End-User, ($bn), 2017-2027
  • Figure 4.1. Global Bio-MEMS & Microfluidics Market, by Type, Market Share (%), 2016
  • Figure 4.2. Global Bio-MEMS & Microfluidics Market, by Type, Forecast ($bn) 2017-2027
  • Figure 4.3. Global Implantable Market for Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.4. Global Implantable Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.5. Global Bio-MEMS & Microfluidics Market for Implantable, by Type, Market Share (%), 2016
  • Figure 4.6. Global Implantable Bio-MEMS & Microfluidics Market for Biosensors, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.7. Global Implantable Bio-MEMS & Microfluidics Market for Gyroscopes, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.8. Global Implantable Bio-MEMS & Microfluidics Market for Stents, by Type, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.9. Global Implantable Bio-MEMS & Microfluidics Market for Drug Delivery Devices, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.10. Global Implantable Bio-MEMS & Microfluidics Market for Biochips, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.11. Global Implantable Bio-MEMS & Microfluidics Market for Accelerometers, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.12. Global Injectable Market for Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.13. Global Injectable Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.14. Global Bio-MEMS & Microfluidics Market for Injectable, by Type, Market Share (%), 2016
  • Figure 4.15. Global Injectable Bio-MEMS & Microfluidics Market for Microneedles, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.16. Global Injectable Bio-MEMS & Microfluidics Market for Micromodules, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.17. Global Other Devices Market for Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn) 2017-2027
  • Figure 4.18. Global Others Devices Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.19. Global Bio-MEMS & Microfluidics Market for Others Devices, by Type, Market Share (%), 2016
  • Figure 4.20. Global Other Devices Bio-MEMS & Microfluidics Market for Inhalers, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.21. Global Other Devices Bio-MEMS & Microfluidics Market for Catheters, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 4.22. Global Other Devices Bio-MEMS & Microfluidics Market for Micro Motors, ($bn, AGR%, CAGR%) 2017-2027
  • Figure 5.1. Global Bio-MEMS & Microfluidics Market, by Application, Market Share (%), 2016
  • Figure 5.2. Global Bio-MEMS & Microfluidics Market, by Application, Forecast ($bn) 2017-2027
  • Figure 5.3. Global Bio-MEMS & Microfluidics Market for Diagnostic Forecast, by Geography, ($bn) 2017-2027
  • Figure 5.4. Global Bio-MEMS & Microfluidics Market for Therapeutics Forecast, by Geography, ($bn) 2017-2027
  • Figure 5.5. Global Bio-MEMS & Microfluidics Market for Tissue Engineering Forecast, by Geography, ($bn) 2017-2027
  • Figure 5.6. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Geography, ($bn) 2017-2027
  • Figure 6.1. Global Bio-MEMS & Microfluidics Market, by End-User, Market Share (%), 2016
  • Figure 6.2. Global Bio-MEMS & Microfluidics Market, by End-User, Forecast ($bn) 2017-2027
  • Figure 6.3. Global Bio-MEMS & Microfluidics Market for Pharmaceuticals Forecast, by Geography, ($bn) 2017-2027
  • Figure 6.4. Global Bio-MEMS & Microfluidics Market for Hospitals Forecast, by Geography, ($bn) 2017-2027
  • Figure 6.5. Global Bio-MEMS & Microfluidics Market for Research Centres Forecast, by Geography, ($bn) 2017-2027
  • Figure 6.6. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Geography, ($bn) 2017-2027
  • Figure 7.1. Global Bio-MEMS & Microfluidics Market, by Geography, ($bn) 2017-2027
  • Figure 7.2. Global Bio-MEMS & Microfluidics Market Forecast, by Geography, Market Share (%), 2016
  • Figure 7.3. North America Bio-MEMS & Microfluidics Market Forecast, by Country($bn) 2017-2027
  • Figure 7.4. North America Bio-MEMS & Microfluidics Market, by Country, Market Share (%), 2016
  • Figure 7.5. USA Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.6. Canada Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.7. Mexico Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.8. South America Bio-MEMS & Microfluidics Market Forecast, by Country($bn) 2017-2027
  • Figure 7.9. South America Bio-MEMS & Microfluidics Market, by Country, Market Share (%), 2016
  • Figure 7.10. Brazil Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.11. Argentina Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.12. Paraguay Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.13. Bolivia Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.14. Rest of South America Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.15. Europe Bio-MEMS & Microfluidics Market Forecast, by Country($bn) 2017-2027
  • Figure 7.16. Europe Bio-MEMS & Microfluidics Market, by Country, Market Share (%), 2016
  • Figure 7.17. France Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.18. Germany Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.19. UK Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.20. Spain Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.21. Italy Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.22. Rest of Europe Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.23. Asia-Pacific Bio-MEMS & Microfluidics Market Forecast, by Country ($bn) 2017-2027
  • Figure 7.24. Asia-Pacific Bio-MEMS & Microfluidics Market, Market Share (%), 2016
  • Figure 7.25. China Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.26. Japan Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.27. India Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.28. Australia Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.29. Thailand Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.30. Rest of Asia-Pacific Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.31. RoW Bio-MEMS & Microfluidics Market, by Country($bn) 2017-2027
  • Figure 7.32. Rest of World Bio-MEMS & Microfluidics Market, by Country, Market Share (%), 2016
  • Figure 7.33. Middle East Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.34. Africa Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 7.35. Other Countries Bio-MEMS & Microfluidics Market Forecast ($bn) 2017-2027
  • Figure 8.1. Porter's Five Forces Analysis of the Bio-MEMS & Microfluidics Market
  • Figure 8.2. Incidence Rate of Chronic Diseases
  • Figure 8.3. USA Healthcare Expenditure per Person
  • Figure 8.4. Rising GDP of Countries
  • Figure 9.1. Abbott Diagnostics , Revenue, ($million), 2012-2016
  • Figure 9.2. Abbott Diagnostics (Segment) , Revenue, ($million), 2012-2016
  • Figure 9.3. Abbott Diagnostics, Product Segments Share (%), 2016
  • Figure 9.4. Abbott Diagnostics, Geographic Presence Share (%), 2016
  • Figure 9.5. Danaher Corporation, Revenue, ($million), 2012-2016
  • Figure 9.6. Danaher Corporation, Product Segments Share (%), 2016
  • Figure 9.7. Danaher Corporation, Geographical Presence Share (%), 2016
  • Figure 9.8. Thermo Fisher Scientific Inc., Revenue, ($million), 2012-2016
  • Figure 9.9. Thermo Fisher Scientific Inc., Product Segments Share (%), 2016
  • Figure 9.10. Thermo Fisher Scientific Inc., Geographical Presence Share (%), 2016
  • Figure 9.11. Medtronic PLC, Revenue, ($million), 2012-2016
  • Figure 9.12. Medtronic PLC, Product Segments Share (%), 2016
  • Figure 9.13. Medtronic PLC, Geographical Presence Share (%), 2016
  • Figure 9.14. Boston Scientific Corporation, Revenue, ($million), 2012-2016
  • Figure 9.15. Boston Scientific Corporation, Product Segments Share (%), 2016
  • Figure 9.16. Boston Scientific Corporation, Geographical Presence Share (%), 2016
  • Figure 9.17. F. Hoffmann-La Roche, Revenue, ($million), 2012-2016
  • Figure 9.18. F. Hoffmann-La Roche, Product Segments Share (%), 2016
  • Figure 9.19. F. Hoffmann-La Roche, Geographical Presence Share (%), 2016
  • Figure 9.20. Johnson & Johnson, Revenue, ($million), 2012-2016
  • Figure 9.21. Johnson & Johnson, Product Segments Share (%), 2016
  • Figure 9.22. Johnson & Johnson, Geographical Presence Share (%), 2016
  • Figure 9.23. Becton, Dickinson and Company, Revenue, ($million), 2012-2016
  • Figure 9.24. Becton, Dickinson and Company, Product Segments Share (%), 2016
  • Figure 9.25. Becton, Dickinson and Company, Geographical Presence Share (%), 2016
  • Figure 10.1. Global Bio-MEMS & Microfluidics Market, by Type, ($bn), 2017-2027
  • Figure 10.2. Global Bio-MEMS & Microfluidics Market, by Application, ($bn), 2017-2027
  • Figure 10.3. Global Bio-MEMS & Microfluidics Market, by End-User, ($bn), 2017-2027
  • Figure 10.4. Global Bio-MEMS & Microfluidics Market, by Geography, ($bn), 2017-2027

List of Tables

  • Table 3.1. Global Bio-MEMS & Microfluidics Forecast ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.1. Global Bio-MEMS & Microfluidics Market Forecast, by Type ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.2. Global Implantable Bio-MEMS & Microfluidics Market Forecast ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.3. Global Implantable Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.4. Global Implantable Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.5. Global Implantable Bio-MEMS & Microfluidics Market for Biosensors, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.6. Global Implantable Bio-MEMS & Microfluidics Market for Gyroscopes, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.7. Global Implantable Bio-MEMS & Microfluidics Market for Stents, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.8. Global Implantable Bio-MEMS & Microfluidics Market for Drug Delivery Devices, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.9. Global Implantable Bio-MEMS & Microfluidics Market for biochips, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.10. Global Implantable Bio-MEMS & Microfluidics Market for Accelerometers, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.11. Global Injectable Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.12. Global Injectable Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.13. Global Injectable Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.14. Global Injectable Bio-MEMS & Microfluidics Market for Microneedles, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.15. Global Injectable Bio-MEMS & Microfluidics Market for Micromodules, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.16. Global Other Bio-MEMS & Microfluidics Devices Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.17. Global Others Devices Bio-MEMS & Microfluidics Market Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.18. Global Others Devices Bio-MEMS & Microfluidics Market, by Type ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.19. Global Other Devices Bio-MEMS & Microfluidics Market for Inhalers, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.20. Global Other Devices Bio-MEMS & Microfluidics Market for Catheters, ($bn, AGR%, CAGR%) 2017-2027
  • Table 4.21. Global Other Devices Bio-MEMS & Microfluidics Market for Micro Motors, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.1. Global Bio-MEMS & Microfluidics Market Forecast, by Application ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.2. Global Bio-MEMS & Microfluidics Market for Diagnostic Forecast, by Application, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.3. Global Bio-MEMS & Microfluidics Market for Diagnostic Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.4. Global Bio-MEMS & Microfluidics Market for Therapeutics Forecast, by Application, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.5. Global Bio-MEMS & Microfluidics Market for Therapeutics Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.6. Global Bio-MEMS & Microfluidics Market for Tissue Engineering Forecast, by Application, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.7. Global Bio-MEMS & Microfluidics Market for Tissue Engineering Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.8. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Application, ($bn, AGR%, CAGR%) 2017-2027
  • Table 5.9. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.1. Global Bio-MEMS & Microfluidics Market Forecast, by End-User ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.2. Global Bio-MEMS & Microfluidics Market for Pharmaceuticals Forecast, by End-User, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.3. Global Bio-MEMS & Microfluidics Market for Pharmaceuticals Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.4. Global Bio-MEMS & Microfluidics Market for Hospitals Forecast, by End-User, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.5. Global Bio-MEMS & Microfluidics Market for Hospitals Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.6. Global Bio-MEMS & Microfluidics Market for Research Centres Forecast, by End-User, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.7. Global Bio-MEMS & Microfluidics Market for Research Centres Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.8. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by End-User, ($bn, AGR%, CAGR%) 2017-2027
  • Table 6.9. Global Bio-MEMS & Microfluidics Market for Others Applications Forecast, by Geography, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.1. Global Bio-MEMS & Microfluidics Market, by Geography ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.2. North America Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.3. USA Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.4. Canada Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.5. Mexico Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.6. South America Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.7. Brazil Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.8. Argentina Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2016-2027
  • Table 7.9. Paraguay Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.10. Bolivia Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.11. Rest of South America Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.12. European Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.13. France Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.14. Germany Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.15. UK Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.16. Spain Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.17. Italy Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.18. Rest of European Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.19. Asia-Pacific Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.20. China Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.21. Japan Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.22. India Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.23. Australia Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.24. Thailand Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.25. Rest of Asia-Pacific Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.26. Rest of World Bio-MEMS & Microfluidics Market Forecast, by Country ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.27. Middle East Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.28. Africa Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 7.29. Other Countries Bio-MEMS & Microfluidics Market Forecast, ($bn, AGR%, CAGR%) 2017-2027
  • Table 8.1. Global Incidence Rate of Diseases
  • Table 9.1. Abbott Diagnostics: Company Overview
  • Table 9.2. Abbott Diagnostics: Product Portfolio
  • Table 9.3. Abbott Diagnostics: Recent Developments
  • Table 9.4. Nova Biomedical: Company Overview
  • Table 9.5. Nova Biomedical: Product Portfolio
  • Table 9.6. Nova Biomedical: Recent Developments
  • Table 9.7. Danaher Corporation: Company Overview
  • Table 9.8. Danaher Corporation: Product Portfolio
  • Table 9.9. Danaher Corporation: Recent Developments
  • Table 9.10. Thermo Fisher Scientific Inc.: Company Overview
  • Table 9.11. Thermo Fisher Scientific Inc.: Product Portfolio
  • Table 9.12. Thermo Fisher Scientific Inc.: Recent Developments
  • Table 9.13. Fraunhofer-IMS: Company Overview
  • Table 9.14. Fraunhofer-IMS: Product Portfolio
  • Table 9.15. Medtronic PLC: Company Overview
  • Table 9.16. Medtronic PLC.: Product Portfolio
  • Table 9.17. Medtronic PLC: Recent Developments
  • Table 9.18. Boston Scientific Corporation: Company Overview
  • Table 9.19. Boston Scientific Corporation: Product Portfolio
  • Table 9.20. Boston Scientific Corporation: Recent Developments
  • Table 9.21. F. Hoffmann-La Roche : Company Overview
  • Table 9.22. F. Hoffmann-La Roche : Product Portfolio
  • Table 9.23. F. Hoffmann-La Roche : Recent Developments
  • Table 9.24. Johnson & Johnson: Company Overview
  • Table 9.25. Johnson & Johnson: Product Portfolio
  • Table 9.26. Johnson & Johnson: Recent Developments
  • Table 9.27. Becton, Dickinson and Company: Company Overview
  • Table 9.28. Becton, Dickinson and Company: Product Portfolio
  • Table 9.29. Becton, Dickinson and Company: Recent Developments

Companies Listed:

  • Abbott Diagnostics
  • Abbott Laboratories Inc
  • Affymetrix
  • Affymetrix
  • Akonni Biosystems
  • Albright Technologies
  • Aline Inc
  • Applied BioPhysics
  • Aquula
  • Arcxis Biotechnologies
  • ArrayJet
  • Artemis Health
  • Axis-Shield
  • Axxicon
  • Baebies
  • Bartels Mikrotechnik
  • Becton, Dickinson and Company
  • BellBrook Laboratories
  • Biodetection instruments
  • Biodot
  • BiofluidiX
  • BioForce Nanosciences
  • Biolithic
  • BioMicro Systems
  • Bionas
  • Bioscale
  • Biosite
  • Biosurfit
  • BioTray
  • BioVitesse
  • Boehringer Ingelheim
  • Boston Microfluidics
  • Boston Scientific Corporation
  • Bürkert Fluid Control Systems
  • Cambridge Biomagnetics
  • Cambridge Consultants
  • Capilix
  • CapitalBio Corporation
  • Carbo Analytics
  • CardioMEMS
  • Cellanyx
  • Cellectricon
  • Cellix
  • Celula
  • Cepheid
  • Cetoni
  • CfBI
  • Chiral Photonics
  • CiDRA Precision Services
  • Claros Diagnostics
  • Clondiag
  • CMC Microsystems
  • CorSolutions
  • Coventor
  • Creative MicroSystems
  • Crospon
  • CSEM
  • Cyclofluidic
  • Cynvenio
  • Cytocentrics Bioscience
  • Cytonome
  • Cytoo
  • Daktari Diagnostics
  • Dalsa
  • Danaher Corporation
  • Debiotech
  • Deltadot
  • DEOS Labs
  • Design Solutions
  • Diagnostics for All
  • Diagnoswiss
  • Digilab Globa
  • DNA Electronics
  • Dolomite Microfluidics
  • Drop-Tech
  • Dyconex
  • EBB Microparts
  • F. HOFFMANN-LA ROCHE AG
  • ForteBio
  • Fraunhofer-IMS
  • Fraunhofer-IMS
  • Johnson & Johnson Ltd.
  • Medtronic PLC
  • Nova Biomedical
  • Nova Medical
  • Pall ForteBio
  • Roche Diagnostics
  • Thermo Fisher Scientific Inc

List of Organisations:

  • FDA
  • Germany's Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)
  • Japanese Ministry of Health, Labour and Welfare
  • NHS
  • NICE
  • WHO
Back to Top